Real-world data show a rise in biomarker testing for primary advanced/recurrent endometrial cancer, especially mismatch repair/microsatellite instability, but disparities in access persist across care...
A new study from Mayo Clinic and Exact Sciences demonstrates that a six-gene methylated DNA marker panel, detectable in vaginal fluid, accurately identifies endometrial cancer in women with abnormal uterine...
A retrospective cohort study found that endometrial biopsies identifying endometrial intraepithelial neoplasia were associated with a higher likelihood of endometrial cancer and high-risk features on final...
A study identified biomarkers associated with response and resistance to nivolumab plus cabozantinib in recurrent endometrial cancer, offering insights for future therapies.
A randomized trial found a minor overall survival benefit for robotic-assisted laparoscopy over coheanventional laparoscopy in endometrial cancer treatment.
Researchers developed a population-based cohort study to determine whether there are associations between endometriosis subtypes and incidence of ovarian cancer.
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A recent retrospective cohort study assessed the prevalence of germline and somatic mutations in patients with ovarian carcinosarcoma and their impact on cancer-related outcomes, highlighting the need for...
A retrospective analysis of the National Cancer Database suggests that incorporating laparoscopy before laparotomy in primary debulking surgery improves overall survival in stage IIIC epithelial ovarian...
